<DOC>
	<DOC>NCT01997294</DOC>
	<brief_summary>Statins have been approved to benefit patients underwent percutaneous coronary intervention (PCI). The current study is designed to evaluate the effectiveness and safety of Sequential Therapy of Atorvastatin in patients with ST-elevated myocardial infarction and receive PCI treatment.</brief_summary>
	<brief_title>Sequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Sighed informed consent Diagnosised as acute myocardial infarction Time frame less than 12 hours since the occurance of chest pain Aggred to receive sirolimuseluted coronary stents Patients willing to accepte followup Allegy to statins or with a history against statin therapy Allegy to any products that will be used during PPCI Disagreed to receive PPCI and other related therapy Existing sever liver dysfuntion that statins can not be used according to the guildlines Sever kidney dysfunction (creatinine &gt;3mg/dl or eGFR&lt;30ml/min) Sever left ventricular dysfunction (Killip grade 3) Patients are currently taking medicine that may influence the use of statin Patients with a history of alcohol abuse or durg abuse Woman during pregnancy or lactation Patients who has attended other clinical trials Patients who has received PCI or CABG previously Patients who can not agree to accept study protocol Other conditions that may not sutible for the current study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>sequential therapy</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>acute myocardial infarction</keyword>
</DOC>